Defecetive Drugs: adrugrecall.com
NEWS
Sign up for our newsletter
to receive breaking news about drugs to watch
Contact A Lawyer
Near You
Contact us today for a complimentary consultation with a qualified attorney near you.
Subscribe To Our Syndicated NewsWarning Issued to Vytorin Users
-September 2, 2008
The warning issued to Vytorin users still stands as results from more studies do nothing to rule out a risk of cancer linked to the drug.
Researchers involved with the study are cautioning patients and doctors before they continue to use and prescribe the drug until more is known.
Studies Conducted to Determine Risks
Studies were recently conducted analyzing the benefits and risks associated with Vytorin and are published in the New England Journal of Medicine.
Vytorin is a cholesterol lowering medication and the possible risk of cancer link arose in July when a study by Dr. Terje Pederson discovered flaws in the drug.
After this initial study, doctors began seeing an increase in the amount of cancer cases among patients prescribed the drug; therefore, more studies were conducted.
The most recent study, conducted at Oxford University in England, found higher rates of cancer and deaths among Vytorin users.
Patients and Doctors Cautioned
Those who have worked on the studies are still weary of the drug and its effects and are cautioning the public to take caution.
"The jury is still out as to whether there's a cancer signal," states Dr. Gordon Tomaselli, the chief of cardiology at Johns Hopkins Hospital and a spokesman for the American Heart Association.
(Source: Associated Press)
Have you been harmed by Vytorin or another cholesterol lowering medication? If so, please contact us today to speak with a trustworthy attorney who can evaluate your case and ensure you receive the legal guidance you need and deserve.
